Drug
Poly-L-Lactic Acid
Poly-L-Lactic Acid is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 66.7%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_4
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Phase Distribution4 total trials
Phase 4Post-market surveillance
4(100.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Terminated(1)
Detailed Status
Completed2
Terminated1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
66.7%
Most Advanced
Phase 4
Trials by Phase
Phase 44 (100.0%)
Trials by Status
terminated125%
recruiting125%
completed250%
Recent Activity
1 active trials
Showing 4 of 4
recruitingphase_4
Treatment of Perioral Wrinkles Using Topical Poly-L-lactic Acid and Microneedling Device
NCT07225348
completedphase_4
Canadian Aesthetic Experience With Sculptra Therapy
NCT00447551
completedphase_4
Poly-L-lactic Acid for Skin Quality
NCT02003833
terminatedphase_4
Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy
NCT00126308
Clinical Trials (4)
Showing 4 of 4 trials
NCT07225348Phase 4
Treatment of Perioral Wrinkles Using Topical Poly-L-lactic Acid and Microneedling Device
NCT00447551Phase 4
Canadian Aesthetic Experience With Sculptra Therapy
NCT02003833Phase 4
Poly-L-lactic Acid for Skin Quality
NCT00126308Phase 4
Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4